药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
3-Methylfentanyl
Tixocortol
The risk or severity of adverse effects can be increased when Tixocortol is combined with Tetrandrine.
3-Methylfentanyl
Vilanterol
The risk or severity of adverse effects can be increased when Vilanterol is combined with Tetrandrine.
3-Methylfentanyl
Dinutuximab
The risk or severity of adverse effects can be increased when Dinutuximab is combined with Tetrandrine.
3-Methylfentanyl
Blinatumomab
The risk or severity of adverse effects can be increased when Blinatumomab is combined with Tetrandrine.
3-Methylfentanyl
Vedolizumab
The risk or severity of adverse effects can be increased when Vedolizumab is combined with Tetrandrine.
3-Methylfentanyl
Fluprednidene
The risk or severity of adverse effects can be increased when Fluprednidene is combined with Tetrandrine.
3-Methylfentanyl
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Tetrandrine.
3-Methylfentanyl
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Tetrandrine.
3-Methylfentanyl
Belimumab
The risk or severity of adverse effects can be increased when Belimumab is combined with Tetrandrine.
3-Methylfentanyl
Eribulin
The risk or severity of adverse effects can be increased when Eribulin is combined with Tetrandrine.
3-Methylfentanyl
Wortmannin
The risk or severity of adverse effects can be increased when Wortmannin is combined with Tetrandrine.
3-Methylfentanyl
Bendamustine
The risk or severity of adverse effects can be increased when Bendamustine is combined with Tetrandrine.
3-Methylfentanyl
Belatacept
The risk or severity of adverse effects can be increased when Belatacept is combined with Tetrandrine.
3-Methylfentanyl
Abetimus
The risk or severity of adverse effects can be increased when Abetimus is combined with Tetrandrine.
3-Methylfentanyl
Mepolizumab
The risk or severity of adverse effects can be increased when Mepolizumab is combined with Tetrandrine.
3-Methylfentanyl
Human interferon omega-1
The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Tetrandrine.
3-Methylfentanyl
Briakinumab
The risk or severity of adverse effects can be increased when Briakinumab is combined with Tetrandrine.
3-Methylfentanyl
Glatiramer
The risk or severity of adverse effects can be increased when Glatiramer is combined with Tetrandrine.
3-Methylfentanyl
Interferon alfa
The risk or severity of adverse effects can be increased when Interferon alfa is combined with Tetrandrine.
3-Methylfentanyl
Trabectedin
The risk or severity of adverse effects can be increased when Trabectedin is combined with Tetrandrine.